Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Electrophoresis ; 20(6): 1204-10, 1999 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10380760

RESUMEN

Deciphering the genetic mechanisms in cancer development requires analysis of a large number of tumors for consistent genetic alterations. Single-strand conformational polymorphism (SSCP) analysis is a fast and efficient method for detecting mutations, deletions, insertions and loss of alleles. The primary advantage of this method is speed and ability to screen a large number of samples at one time. Here we report the use of the SSCP technique for rapidly screening tumor and normal tissues for mutations and polymorphisms in the p53 tumor suppressor gene. Because the DNA extracted from specific aberrant bands from different samples always give rise to the same nucleotide sequence upon sequencing analysis, the SSCP technique can be used as a diagnostic tool to identify the presence of such genetic alterations without having to spend time on further sequencing analysis.


Asunto(s)
Genes p53 , Mutación , Reacción en Cadena de la Polimerasa/métodos , Polimorfismo Genético , Polimorfismo Conformacional Retorcido-Simple , Humanos
2.
Cancer Res ; 59(9): 2072-5, 1999 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-10232590

RESUMEN

The relationship between nitric oxide synthase II (NOS II) inducibility and the metastatic ability of UV-2237 murine fibrosarcoma cells was determined. Highly metastatic cells survived to produce numerous lung metastases after i.v. injection in syngeneic C3H/HeN mice, whereas poorly metastatic cells did not. Highly metastatic clones exhibited higher levels of NOS II than did poorly metastatic clones in response to interleukin 1alpha and IFN-gamma stimulation. Furthermore, both poorly and highly metastatic clones contained an identical p53 mutation. Overexpression of NOS II in a highly metastatic clone by transfection with NOS II gene retarded tumor growth and completely suppressed metastasis. Our data indicate that a low to moderate level of NOS II expression directly correlates with metastatic ability of UV-2237 fibrosarcoma cells carrying mutant p53 and that a high level of nitric oxide production suppresses tumor growth and metastasis.


Asunto(s)
Fibrosarcoma/patología , Genes p53 , Metástasis de la Neoplasia/genética , Proteínas de Neoplasias/biosíntesis , Óxido Nítrico Sintasa/biosíntesis , Óxido Nítrico/fisiología , Animales , Inducción Enzimática , Fibrosarcoma/genética , Ratones , Ratones Endogámicos C3H , Proteínas de Neoplasias/genética , Trasplante de Neoplasias , Neoplasias Inducidas por Radiación/genética , Neoplasias Inducidas por Radiación/patología , Óxido Nítrico Sintasa/genética , Óxido Nítrico Sintasa de Tipo II , Proteínas Recombinantes de Fusión/fisiología , Transfección , Células Tumorales Cultivadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA